Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Thalidomide × 1 year × Clear all

Phase

Status

Sponsor Class

OTHER 12 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 50 Magnetic Resonance Spectroscopy 41 Cyclophosphamide 35 Vincristine 28 Carboplatin 26 Radiation 25 Cisplatin 25 Radiotherapy 24 Etoposide 22 Dexamethasone 20 Doxorubicin 19 Biopsy 19 daratumumab 15 Irinotecan 15 durvalumab 14 Radiotherapy, Intensity-Modulated 14 Paclitaxel 14 Observation 13 Prednisone 12 Platinum 12 Lenalidomide 12 Fluorouracil 12 1,2-diaminocyclohexaneplatinum II citrate 12 Leucovorin 11 Docetaxel 11 Cytarabine 11 Bortezomib 11 Watchful Waiting 10 Stem Cell Transplantation 10 Methotrexate 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02541383 2025-04-13

Cassiopeia

Intergroupe Francophone du Myelome

Phase 3 Completed

1,085 enrolled 22 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡